Citadel Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-501,911
| Closed | -$269K | – | 7300 |
|
2024
Q4 | $269K | Buy |
501,911
+261,506
| +109% | +$140K | ﹤0.01% | 4629 |
|
2024
Q3 | $423K | Buy |
240,405
+236,840
| +6,643% | +$417K | ﹤0.01% | 3963 |
|
2024
Q2 | $4.17K | Sell |
3,565
-1,240,275
| -100% | -$1.45M | ﹤0.01% | 5604 |
|
2024
Q1 | $11.2M | Buy |
1,243,840
+647,444
| +109% | +$5.85M | ﹤0.01% | 1227 |
|
2023
Q4 | $6.48M | Buy |
596,396
+118,387
| +25% | +$1.29M | ﹤0.01% | 1494 |
|
2023
Q3 | $3.85M | Buy |
478,009
+175,697
| +58% | +$1.41M | ﹤0.01% | 1831 |
|
2023
Q2 | $3.28M | Buy |
302,312
+118,904
| +65% | +$1.29M | ﹤0.01% | 2023 |
|
2023
Q1 | $1.27M | Sell |
183,408
-169,045
| -48% | -$1.17M | ﹤0.01% | 2958 |
|
2022
Q4 | $1.4M | Buy |
352,453
+120,625
| +52% | +$480K | ﹤0.01% | 2901 |
|
2022
Q3 | $1.54M | Buy |
231,828
+12,338
| +6% | +$82K | ﹤0.01% | 2996 |
|
2022
Q2 | $1.06M | Buy |
219,490
+191,640
| +688% | +$927K | ﹤0.01% | 3343 |
|
2022
Q1 | $261K | Sell |
27,850
-196,490
| -88% | -$1.84M | ﹤0.01% | 5066 |
|
2021
Q4 | $2.67M | Buy |
224,340
+172,888
| +336% | +$2.05M | ﹤0.01% | 2731 |
|
2021
Q3 | $585K | Sell |
51,452
-163,563
| -76% | -$1.86M | ﹤0.01% | 4361 |
|
2021
Q2 | $3.86M | Buy |
215,015
+185,724
| +634% | +$3.33M | ﹤0.01% | 2462 |
|
2021
Q1 | $453K | Buy |
+29,291
| New | +$453K | ﹤0.01% | 4654 |
|
2020
Q4 | – | Sell |
-52,028
| Closed | -$668K | – | 5722 |
|
2020
Q3 | $668K | Buy |
52,028
+41,244
| +382% | +$530K | ﹤0.01% | 3255 |
|
2020
Q2 | $109K | Sell |
10,784
-12,955
| -55% | -$131K | ﹤0.01% | 4223 |
|
2020
Q1 | $192K | Buy |
23,739
+6,498
| +38% | +$52.6K | ﹤0.01% | 4098 |
|
2019
Q4 | $149K | Sell |
17,241
-5,601
| -25% | -$48.4K | ﹤0.01% | 4210 |
|
2019
Q3 | $141K | Sell |
22,842
-58,469
| -72% | -$361K | ﹤0.01% | 4199 |
|
2019
Q2 | $1.35M | Sell |
81,311
-12,597
| -13% | -$209K | ﹤0.01% | 2733 |
|
2019
Q1 | $1.57M | Buy |
93,908
+30,561
| +48% | +$511K | ﹤0.01% | 2500 |
|
2018
Q4 | $727K | Buy |
63,347
+24,411
| +63% | +$280K | ﹤0.01% | 3013 |
|
2018
Q3 | $1.56M | Buy |
38,936
+30,054
| +338% | +$1.2M | ﹤0.01% | 2389 |
|
2018
Q2 | $251K | Buy |
8,882
+4,700
| +112% | +$133K | ﹤0.01% | 3552 |
|
2018
Q1 | $64K | Sell |
4,182
-251,346
| -98% | -$3.85M | ﹤0.01% | 3707 |
|
2017
Q4 | $8.34M | Buy |
255,528
+242,682
| +1,889% | +$7.92M | 0.01% | 1041 |
|
2017
Q3 | $301K | Buy |
12,846
+9,843
| +328% | +$231K | ﹤0.01% | 2994 |
|
2017
Q2 | $16K | Sell |
3,003
-5,953
| -66% | -$31.7K | ﹤0.01% | 3554 |
|
2017
Q1 | $64K | Buy |
+8,956
| New | +$64K | ﹤0.01% | 3375 |
|